SCHEMBL1017675

SCHEMBL1017675

O=C(CN1CCc2cc(-n3ncc4ccccc43)ccc2C1)N1CCN(C2CCC2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 2/20 0.41
MAPK10 P53779 2/20 0.41
SIGMAR1 Q99720 7/20 0.41
TMEM97 Q5BJF2 5/20 0.41
PARP1 P09874 1/20 0.40
MGLL Q99685 1/20 0.40
HSD17B10 Q99714 3/20 0.39
ALDH1A1 P00352 3/20 0.39
POLB P06746 2/20 0.39
RECQL P46063 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GAA P10253 1/20 0.39
PKM P14618 1/20 0.39
HRH3 Q9Y5N1 3/20 0.39
HTR1A P08908 2/20 0.39
HRH2 P25021 2/20 0.39
HRH1 P35367 2/20 0.39
CHRM4 P08173 1/20 0.39
CHRM5 P08912 1/20 0.39
ADRA2A P08913 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1016931 0.82 PARP1 (0.41) SIGMAR1TMEM97PARP1HSD17B10ALDH1A1
SCHEMBL1014992 0.82 TMEM97 (0.42) SIGMAR1TMEM97PARP1HSD17B10ALDH1A1
SCHEMBL1017670 0.81 TMEM97 (0.41) SIGMAR1TMEM97PARP1HSD17B10ALDH1A1
SCHEMBL1014022 0.80 HRH3 (0.48) SIGMAR1TMEM97PARP1HSD17B10ALDH1A1
SCHEMBL1018373 0.79 TMEM97 (0.40) SIGMAR1TMEM97PARP1HSD17B10ALDH1A1
SCHEMBL1019875 0.79 ALDH1A1 (0.44) SIGMAR1TMEM97PARP1HSD17B10ALDH1A1
SCHEMBL1014648 0.79 ALDH1A1 (0.39) SIGMAR1TMEM97PARP1HSD17B10ALDH1A1
SCHEMBL1018644 0.79 ALDH1A1 (0.59) PARP1HSD17B10ALDH1A1GAAPKM
SCHEMBL1016821 0.78 ALDH1A1 (0.45) SIGMAR1TMEM97PARP1HSD17B10ALDH1A1
SCHEMBL1016153 0.78 ALDH1A1 (0.48) SIGMAR1TMEM97PARP1HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795262-B2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION (US) 2010-09-14 US claimed
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES LIGAND PHARMACEUTICALS, INC. (US) 2011-04-07 US disclosed
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES LIGAND PHARMACEUTICALS, INC. (US) 2011-04-07 US disclosed
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES LIGAND PHARMACEUTICALS, INC. (US) 2011-04-07 US disclosed
EP-1998620-B1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES NEUROGEN CORP (US) 2011-01-12 EP disclosed
US-7795262-B2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION (US) 2010-09-14 US disclosed
US-7795262-B2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION (US) 2010-09-14 US disclosed
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION 2007-10-04 US disclosed
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION 2007-10-04 US disclosed
WO-2007106349-A2 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2007-09-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues HRH3, HRH4, HRH1 MAPK8 4139/4885MAPK10 3823/4885SIGMAR1 111/4885
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 MAPK8 4139/4885MAPK10 3823/4885SIGMAR1 111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.